Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation - PubMed (original) (raw)
Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation
G Chen et al. J Neurosci. 1999.
Abstract
Recent evidence has shown that brain-derived neurotrophic factor (BDNF) is involved in hippocampal long-term potentiation (LTP). Because the reagents used in acute experiments react not only with BDNF but also with neurotrophin-4/5 (NT4/5) and neurotrophin-3 (NT3), we examined the involvement of these neurotrophins in LTP using two highly specific, function-blocking monoclonal antibodies against BDNF and NT3, as well as a TrkB-IgG fusion protein. Our results show that NT3 antibodies did not have any effects on LTP. However, both TrkB-IgG fusion proteins and BDNF antibody similarly reduced LTP, suggesting that only BDNF but no other ligands of the TrkB-receptor are likely to be involved in LTP induction. The reduction in LTP depended on the inducing stimuli and was only observed with theta-burst stimulation (TBS) but not with tetanic stimulation. We further observed that LTP was only reduced if BDNF was blocked before and during TBS stimulation, and BDNF antibodies did not affect early or late stages of LTP if they were applied 10, 30, or 60 min after TBS stimulation. These results point toward a specific and unique role of endogenous BDNF but not of other neurotrophins in the process of TBS-induced hippocampal LTP. Additionally, they suggest that endogenous BDNF is required for a limited time period only shortly before or around LTP induction but not during the whole process of LTP.
Figures
Fig. 1.
Basal synaptic transmission at the Schaffer collateral–CA1 pathway of hippocampal slices is not affected by treatment with TrkB-IgG fusion protein or BDNF antibody. The slope of field EPSPs was plotted against stimulus strength (in microamperes).A, TrkB-IgG fusion protein (triangles,dotted line; n = 7 slices, 4 mice) and controls (diamonds, solid line;n = 8 slices, 4 mice) (_p_> 0.2). B, BDNF antibody (triangles,dotted line; n = 8 slices, 4 mice) and controls (diamonds, solid line;n = 7 slices, 4 mice) (_p_> 0.3).
Fig. 2.
Short-term plasticity measured by PPF remains normal and unaffected at the Schaffer collateral–CA1 pathway of hippocampal slices after treatment with TrkB-IgG fusion protein or BDNF antibody. Plot depicting the percent ratio of responses to the second pulse relative to the first one. Pairs of pulses were delivered at interpulse intervals of 30, 40, 60, and 100 msec. A, TrkB-IgG fusion protein-treated slices (triangles,dotted line; n = 7 slices, 4 mice) versus control slices (diamonds, solid line; n = 8 slices, 4 mice). B, BDNF antibody-treated slices (triangles, dotted line; n = 8 slices, 4 mice) versus control slices (diamonds, solid line;n = 7 slices, 4 mice).
Fig. 3.
Effects of blocking all endogenous TrkB ligands on LTP. Pretreatment with TrkB-IgG fusion protein for 1 hr reduces LTP in a stimulus-dependent manner; only LTP induced by TBS at the Schaffer collateral–CA1 synapses of hippocampal slices is affected but not LTP induced by tetanic stimulation. Field EPSP slopes were plotted as percent of baseline (mean ± SEM). Straight black line represents the presence of TrkB-IgG fusion protein.First data point after LTP induction represents PTP.A, Tetanus-induced LTP and the effects of TrkB-IgG fusion protein (TrkB-IgG, n = 6 slices, 4 mice; control, n = 6 slices, 4 mice). B, TBS-induced LTP and the effects of TrkB-IgG fusion protein (TrkB-IgG,n = 7 slices, 4 mice; control,n = 5 slices, 4 mice).
Fig. 4.
Effect of selectively blocking endogenous BDNF on LTP. Pretreatment with BDNF antibody for 1 hr significantly reduces LTP induced by TBS but not by tetanic stimulation. A, Effects of BDNF antibody on tetanus-induced LTP (BDNF Ab,n = 7 slices, 4 mice; control,n = 7 slices, 4 mice). B, Effects of BDNF antibody on TBS-induced LTP (BDNF Ab, n = 6 slices, 4 mice; control, n = 7 slices, 4 mice).
Fig. 5.
Effect of blocking endogenous NT3 on LTP. NT3 antibody does not affect LTP induced by either tetanus or TBS. Pretreatment time for slices was again 1 hr before recordings were started. A, Effects of NT3 antibody on tetanus-induced LTP (NT3 Ab, n = 14 slices, 10 mice; control,n = 15 slices, 9 mice). B, Effects of NT3 antibody on TBS-induced LTP (NT3 Ab, n = 13 slices, 10 mice; control, n = 11 slices, 8 mice).
Fig. 6.
Effect on LTP is dependent on the time when endogenous BDNF is blocked by the antibodies. A, BDNF antibodies do not reduce LTP significantly when applied 10 min after TBS. B, Applications 30 or 60 min after TBS also do not affect LTP and its maintenance. Field EPSP slopes were plotted as percent of baseline. Bars indicate level of LTP at the end of each recording averaged over a 5 min period. Late phase LTP (3 hr after TBS) was measured for 30 and 60 min treatment groups (10 min group: BDNF Ab, n = 9 slices, 7 mice; control,n = 8 slices, 7 mice; 30 min group: BDNF Ab,n = 6 slices, 6 mice; control,n = 4 slices, 4 mice; 60 min group: BDNF Ab,n = 5 slices, 5 mice; control,n = 5 slices, 5 mice).
Similar articles
- Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation.
Kang H, Welcher AA, Shelton D, Schuman EM. Kang H, et al. Neuron. 1997 Sep;19(3):653-64. doi: 10.1016/s0896-6273(00)80378-5. Neuron. 1997. PMID: 9331355 - Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus.
Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. Figurov A, et al. Nature. 1996 Jun 20;381(6584):706-9. doi: 10.1038/381706a0. Nature. 1996. PMID: 8649517 - A role for BDNF in the late-phase of hippocampal long-term potentiation.
Korte M, Kang H, Bonhoeffer T, Schuman E. Korte M, et al. Neuropharmacology. 1998 Apr-May;37(4-5):553-9. doi: 10.1016/s0028-3908(98)00035-5. Neuropharmacology. 1998. PMID: 9704996 - Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS.
Lessmann V. Lessmann V. Gen Pharmacol. 1998 Nov;31(5):667-74. doi: 10.1016/s0306-3623(98)00190-6. Gen Pharmacol. 1998. PMID: 9809461 Review. - BDNF mechanisms in late LTP formation: A synthesis and breakdown.
Panja D, Bramham CR. Panja D, et al. Neuropharmacology. 2014 Jan;76 Pt C:664-76. doi: 10.1016/j.neuropharm.2013.06.024. Epub 2013 Jul 2. Neuropharmacology. 2014. PMID: 23831365 Review.
Cited by
- Exercise induction at expression immediate early gene (c-Fos, ARC, EGR-1) in the hippocampus: a systematic review.
Rahmi U, Goenawan H, Sylviana N, Setiawan I, Putri ST, Andriyani S, Fitriana LA. Rahmi U, et al. Dement Neuropsychol. 2024 Apr 15;18:e20230015. doi: 10.1590/1980-5764-DN-2023-0015. eCollection 2024. Dement Neuropsychol. 2024. PMID: 38628561 Free PMC article. Review. - Phenobarbital does not worsen outcomes of neonatal hypoxia on hippocampal LTP on rats.
Sanchez-Brualla I, Ghosh A, Gibatova VA, Quinlan S, Witherspoon E, Vicini S, Forcelli PA. Sanchez-Brualla I, et al. Front Neurol. 2023 Nov 21;14:1295934. doi: 10.3389/fneur.2023.1295934. eCollection 2023. Front Neurol. 2023. PMID: 38073649 Free PMC article. - Repetitive transcranial magnetic stimulation promotes neurological functional recovery in rats with traumatic brain injury by upregulating synaptic plasticity-related proteins.
Qian FF, He YH, Du XH, Lu HX, He RH, Fan JZ. Qian FF, et al. Neural Regen Res. 2023 Feb;18(2):368-374. doi: 10.4103/1673-5374.346548. Neural Regen Res. 2023. PMID: 35900432 Free PMC article. - Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer's Disease.
Xue B, Waseem SMA, Zhu Z, Alshahrani MA, Nazam N, Anjum F, Habib AH, Rafeeq MM, Nazam F, Sharma M. Xue B, et al. Front Neurosci. 2022 May 25;16:925991. doi: 10.3389/fnins.2022.925991. eCollection 2022. Front Neurosci. 2022. PMID: 35692417 Free PMC article. Review. - Androgen Effects on Neural Plasticity.
Kuwahara N, Nicholson K, Isaacs L, MacLusky NJ. Kuwahara N, et al. Androg Clin Res Ther. 2021 Dec 23;2(1):216-230. doi: 10.1089/andro.2021.0022. eCollection 2021. Androg Clin Res Ther. 2021. PMID: 35024693 Free PMC article. Review.
References
- Airaksinen MS, Meyer M. Most classes of dorsal root ganglion neurons are severely depleted but not absent in mice lacking neurotrophin-3. Neuroscience. 1996;73:907–911. - PubMed
- Airaksinen MS, Koltzenburg M, Lewin GR, Masu Y, Helbig C, Wolf E, Brem G, Toyka KV, Thoenen H, Meyer M. Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation. Neuron. 1996;16:287–295. - PubMed
- Berninger B, Poo M-M. Fast action of neurotrophic factors. Curr Opin Neurobiol. 1996;6:324–330. - PubMed
- Blöchl A, Thoenen H. Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur J Neurosci. 1995;7:1220–1228. - PubMed
- Blöchl A, Berninger B, Berzaghi M, Castrén E, Lindholm D, Thoenen H. Neurotrophins as mediators of neuronal plasticity. In: Ibanez CF, editor. Life and death in the nervous system. Elsevier; Oxford: 1995. pp. 260–272.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources